TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| BioLeap to aid GlaxoSmithKline in drug development BioLeap entered into an agreement Tuesday to design lead therapeutic compounds for “difficult” drug targets identified by and for GlaxoSmithKline. (GSK) feeds.bizjournals.com |
Glaxo's Big Bet on Battling Pandemics Glaxo spent years fashioning itself into a one-stop pandemic shop. Now, as the swine-flu virus sweeps the globe, it will find out if the world is buying. online.wsj.com |
States Sue Amgen Over Sales Practices Fourteen states sued Amgen, alleging the drug-maker provided doctors with retreats and other incentives to prescribe anemia-drug Aranesp. online.barrons.com |
Good News for Dynavax HBV Vaccine Zacks.com submits: Dynavax Technologies Corp. (DVAX) announced recently that it has received approval from the European Union to make part of its hepatitis B vaccine (HBV) Heplisav at a German factory. The EU approval permits Dynavax to commercially produce hepatitis B surface antigen, a key component of Heplisav at the factory in Düsseldorf, in the west central part of Germany.Rhein Biotech, a German unit of Dynavax, has used this facility to manufacture the hepatitis B surface antigen for Heplisav studies since 2006. The factory has been upgraded since then. The current EU nod comes as a result of the upgrade, thereby expanding production capacity. The new license should enable the facility to meet initial commercial production demands for the anticipated launch of the HBV vaccine. Furthermore, the upgraded facility enhances integrated product development and manufacturing services provided by the German subsidiary to third party partners.Complete Story » seekingalpha.com |
The Scales Can Lie: Hidden Fat Can you be normal weight and fat at the same time? A Mayo Clinic report suggests that fat in your body can get you and your heart into trouble even if the scale tells you you're healthy. online.wsj.com |